Abstract Multiple cardiac rhabdomyomas in an infant presented with recurrent life-threatening ventricular arrhythmias refractory to medical treatment and necessitating the placement of an implantable cardioverter defibrillator (ICD). The device functioned effectively as a bridge to recovery during a 2-year follow-up period, when the tumor showed spontaneous regression, along with an almost complete resolution of the ventricular arrhythmias. We conclude that childhood cardiac rhabdomyomas causing severe drug-refractory ventricular arrhythmias can be managed by ICD therapy.
Introduction
Cardiac rhabdomyoma (CR) is the most common primary cardiac tumor in childhood, with a reported incidence of 0.02 to 0.08% in live-born infants [8] . It is predominantly a benign tumor that tends to appear between 20 and 30 weeks gestation and regresses spontaneously in the first few years of life [6] , but is strongly associated with tuberous sclerosis, which largely determines the long-term outcome [5] . The natural history of CR can be complicated by hemodynamic abnormalities, such as outflow tract obstruction, myocardial depression, or electrical abnormalities in the form of ventricular and supraventricular arrhythmias and conduction block [1, 9, 10] . We report a case of an infant with CR presenting with multiple life-threatening ventricular arrhythmias refractory to medical treatment necessitating the placement of an implantable cardioverter defibrillator (ICD).
Case report
A 40-day-old, previously healthy, female infant presented with cardiac arrest due to ventricular fibrillation (VF) at home. After successful cardiopulmonary resuscitation and defibrillation at another hospital, she was admitted to our hospital's intensive care unit. She was born prematurely at 34 weeks gestational age and with a birth weight of 2,300 g. The gravidity was uneventful, hence, an antenatal screening ultrasound was not performed in accordance with the prenatal protocol of the Netherlands at that time. There was no significant neonatal or family history.
The electrocardiogram on admission showed a sinus rhythm with normal conduction intervals and severe ST segment depression in the precordial leads (Fig. 1) . The echocardiogram revealed multiple, large tumors in both ventricles, but predominantly in the left ventricle (Fig. 2a) . The tumors caused no inflow or outflow tract obstruction. Since CR was suspected, a work-up for the presence of localizations of tuberous sclerosis was performed. Magnetic resonance imaging (MRI) of the brain and kidneys, andabnormalities. In addition, DNA analysis for the tuberous sclerosis (TSC2) gene was negative. Coronary angiography confirmed the echocardiographic findings and showed normal coronary artery anatomy without any compression.
The child experienced frequent episodes of very fast polymorphic ventricular tachycardia (VT), with rates of more than 300 beats per minute. There were numerous runs of nonsustained VTs lasting several seconds to minutes and, weekly, there were several episodes of fast sustained VT with loss of consciousness requiring cardiac defibrillation (Fig. 3) . Ventricular arrhythmias were refractory to single-drug therapies, including beta blockers, flecainide, and amiodarone. Echocardiographic studies showed mild progression of the cardiac tumors. After 3 months in hospital, in view of refractory ventricular arrhythmias as well as tumor progression, cardiac biopsy was performed through catheterization, which confirmed the diagnosis of rhabdomyomas.
Eventually, ventricular arrhythmias could be partially suppressed with the combination of amiodarone (10 mg/kg) and flecainide (6 mg/kg). In the following months, the child's clinical condition gradually stabilized and ICD was first considered as a treatment option at this stage. Nonsustained VT episodes continued, but the occurrence of sustained VT decreased. Cardiac defibrillation, however, remained frequently necessary. At the age of 8 months, a subcutaneous ICD system was implanted. The ICD patch electrode was positioned subcutaneously in the left lateral thorax, the ventricular bipolar lead epicardially on the right ventricular apex, and the ICD generator submuscularly in the right upper abdomen. The defibrillation threshold was 10J. After a long and stormy 7-month hospital admission, the child was discharged home two weeks after ICD placement. There were no ICD shocks recorded during the period between device implant and discharge from hospital.
During 2 years of follow-up, she received three appropriate shocks for sustained polymorphic VT. ICD registrations revealed many episodes of non-sustained VTs that significantly decreased with time. The latest follow-up at the age of 2.5 years showed an almost complete disappearance of ventricular arrhythmias, correlating with near total regression of the tumors (Fig. 2b) . Her neurocognitive and psychomotor development have been appropriate for age. The patient still receives daily amiodarone 8 mg/kg and flecainide 6 mg/kg, and the thyroid function remains normal. The drug dosage has been planned for a gradual step-down, with a possibility of the cessation of medication in the following year. Eventually, the ICD system will be removed if the child remains free of arrhythmias without drug therapy.
Discussion
CR is known to regress in the postnatal period. However, in a recently published meta-analysis on antenatally diagnosed cases, it was shown that CR may have a high prenatal and neonatal mortality. The size of the cardiac tumors, fetal dysrhythmias, and hydrops were shown to be strong predictors of poor outcome [3] . CRs may be single or multiple, and are predominantly located in the ventricles and interventricular septum, and less frequently in the atria. Depending on the size and location, the tumors can also cause inflow and outflow tract obstruction. Cardiac fibroma is the next most common arrhythmia-inducing pediatric cardiac tumor. However, they are almost always single and, thus, amenable to surgical excision.
The possible electrocardiographic findings include a variety of conduction defects, prolonged PR interval, nonspecific ST-T wave changes, Wolff-Parkinson-White syndrome, and aberrant intraventricular conduction, in addition to findings of right or left ventricular hypertrophy Fig. 3 The upper panel shows the onset of ventricular tachycardia. The lower panel is the corresponding rhythm strip for the episode of ventricular tachycardia and right atrial enlargement. Presenting arrhythmias in CR include supraventricular and ventricular tachycardias, as well as bradyarrhythmias.
Ventricular arrhythmias in CR can be incessant and difficult to control with antiarrhythmic drugs. The management of drug-refractory ventricular arrhythmias in infancy often requires a combination of antiarrhythmic drugs, such as flecainide with amiodarone or sotalol [4, 11] . There are some reports of the surgical excision of solitary tumors that cause mechanical or electrical complications and, at times, surgical ablation has been sought for CR causing supraventricular tachycardia [2, 7, 14] . In the present case, single-drug therapies failed and, subsequently, different antiarrhythmic drug combinations were used. Surgical excision and ablation were not considered in this patient due to multiple widespread tumors. Ventricular arrhythmias were partially controlled with high dosages of amiodarone and flecainide; however, the risk of malignant arrhythmias and sudden cardiac death remained significant. This is the first reported case of CR where an ICD was used as a successful approach to overcome life-threatening ventricular arrhythmias in an infant. ICDs are increasingly used in the pediatric population for both primary and secondary prevention [12] . However, pediatric ICD therapy, in addition to being limited by the small size of infants, may also be associated with complications such as infection of the device system, lead dislodgement and fracture, and a relatively higher rate of inappropriate shocks than in adults. In our patient, we used a novel technique for ICD implantation in infants as reported by Stephenson et al. [13] . The ICD generator is placed in the abdomen and a subcutaneous finger array or patch electrode is positioned in the left thorax. The ventricular sensing and pacing lead is then placed epicardially or transvenously. This technique avoids complications associated with epicardial or transvenous ICD systems, such as restrictive pericarditis, thoracotomy-related issues, and venous occlusion in young children. The subcutaneous ICD system in our patient has proved to function very effectively during a follow-up period of 2 years.
Conclusion
In conclusion, cardiac rhabdomyoma (CR) is a benign tumor that regresses during the first few years of life. However, CR can be complicated by potentially fatal ventricular arrhythmias that can be difficult to suppress with antiarrhythmic drugs. ICD therapy can act as a bridge to electrical recovery during the course of this self-limiting disease.
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